{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-077323","form_type":"8-K/A","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.962552+00:00","generated_at":"2026-05-31T23:50:02.217346+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Zura Bio boosts CEO Lisicki's salary to $585k, bonus target to 50%","bullets":["CEO Robert Lisicki's base salary increased from $440k to $585k, retroactive to April 8, 2024.","Target bonus opportunity raised from 40% to 50% of base salary, effective same date.","Board approved compensation changes on July 1, 2024; CEO transition from Someit Sidhu previously disclosed March 24."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-077323","json":"https://secwatch.observer/filing/0001104659-24-077323.json","markdown":"https://secwatch.observer/filing/0001104659-24-077323.md","text":"https://secwatch.observer/filing/0001104659-24-077323.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924077323/0001104659-24-077323-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924077323/tm2418704d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:50:02.217346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}